ARCHIVES

Part One Of A Two-Part Interview With NCI Director Harold Varmus

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

In Brief: GM Prizes To Withers, Cory, Korsmeyer, Horvitz; Univ. of Chicago, City of Hope Are Comprehensive

May 1, 1998

NCI Plans a Catalog Of Research Tools

April 30, 1999

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991